These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 21734344)

  • 1. Asymmetric dimethylarginine (ADMA) levels display a morning peak in patients with acute myocardial infarction.
    Bergheanu SC; van der Laarse A; van der Bom JG; van der Hoeven BL; le Cessie S; de Jong MG; Liem SS; Schalij MJ; Jukema JW
    Dis Markers; 2011; 30(5):245-52. PubMed ID: 21734344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between Body Mass Index, Asymmetric Dimethylarginine and Risk of Cardiovascular Events and Mortality in Norwegian Patients with Suspected Stable Angina Pectoris.
    Borgeraas H; Hertel JK; Svingen GF; Pedersen ER; Seifert R; Nygård O; Hjelmesæth J
    PLoS One; 2016; 11(3):e0152029. PubMed ID: 27003294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated plasma asymmetric dimethylarginine level in acute myocardial infarction patients as a predictor of poor prognosis and angiographic impaired reperfusion.
    Sen N; Ozlu MF; Akgul EO; Kanat S; Cayci T; Turak O; Yaman H; Sokmen E; Ozcan F; Maden O; Demir AD; Covic A; Kanbay M
    Atherosclerosis; 2011 Nov; 219(1):304-10. PubMed ID: 21726864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High levels of asymmetric dimethylarginine are strongly associated with low HDL in patients with acute myocardial infarction.
    Lorin J; Guilland JC; Korandji C; Touzery C; Bichat F; Chagnon A; Cottin Y; Rochette L; Vergely C; Zeller M
    PLoS One; 2013; 8(6):e64796. PubMed ID: 23755144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between blood asymmetric dimethylarginine level and the complications of patients with cardiovascular diseases.
    Wang D; Lai LH; Yan P; Dong PS
    J Biol Regul Homeost Agents; 2017; 31(1):133-139. PubMed ID: 28337882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-3 polyunsaturated fatty acids early supplementation improves ultrasound indices of endothelial function, but not through NO inhibitors in patients with acute myocardial infarction: N-3 PUFA supplementation in acute myocardial infarction.
    Haberka M; Mizia-Stec K; Mizia M; Janowska J; Gieszczyk K; Chmiel A; Zahorska-Markiewicz B; Gąsior Z
    Clin Nutr; 2011 Feb; 30(1):79-85. PubMed ID: 20705373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma levels of asymmetrical dimethylarginine and adverse cardiovascular events after percutaneous coronary intervention.
    Lu TM; Ding YA; Lin SJ; Lee WS; Tai HC
    Eur Heart J; 2003 Nov; 24(21):1912-9. PubMed ID: 14585249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Higher serum asymmetric dimethylarginine is related to higher risk of heart failure in the EPIC-Potsdam study.
    Wirth J; Atzler D; di Giuseppe R; Cordts K; Menzel J; Böger RH; Boeing H; Weikert C; Schwedhelm E
    Amino Acids; 2017 Jan; 49(1):173-182. PubMed ID: 27796501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship of baseline plasma ADMA levels to cardiovascular outcomes at 2 years in men with acute coronary syndrome referred for coronary angiography.
    Cavusoglu E; Ruwende C; Chopra V; Yanamadala S; Eng C; Pinsky DJ; Marmur JD
    Coron Artery Dis; 2009 Mar; 20(2):112-7. PubMed ID: 19240644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated Levels of Asymmetric Dimethylarginine (ADMA) in the Pericardial Fluid of Cardiac Patients Correlate with Cardiac Hypertrophy.
    Nemeth Z; Cziraki A; Szabados S; Biri B; Keki S; Koller A
    PLoS One; 2015; 10(8):e0135498. PubMed ID: 26313940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum trans fatty acids, asymmetric dimethylarginine and risk of acute myocardial infarction and mortality in patients with suspected coronary heart disease: a prospective cohort study.
    Borgeraas H; Hertel JK; Seifert R; Berge RK; Bohov P; Ueland PM; Nygård O; Hjelmesæth J
    Lipids Health Dis; 2016 Feb; 15():38. PubMed ID: 26920731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylated arginines in stable and acute patients with coronary artery disease before and after percutaneous revascularization.
    Frøbert O; Hjortshøj SP; Simonsen U; Ravkilde J
    Int J Cardiol; 2008 Sep; 129(2):288-91. PubMed ID: 17689741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of asymmetric dimethylarginine on mortality after acute myocardial infarction.
    Zeller M; Korandji C; Guilland JC; Sicard P; Vergely C; Lorgis L; Beer JC; Duvillard L; Lagrost AC; Moreau D; Gambert P; Cottin Y; Rochette L
    Arterioscler Thromb Vasc Biol; 2008 May; 28(5):954-60. PubMed ID: 18276906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated plasma concentrations of the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine predict adverse events in patients undergoing noncardiac surgery.
    Maas R; Dentz L; Schwedhelm E; Thoms W; Kuss O; Hiltmeyer N; Haddad M; Klöss T; Standl T; Böger RH
    Crit Care Med; 2007 Aug; 35(8):1876-81. PubMed ID: 17581491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Asymmetric dimethylarginine predicts major adverse cardiovascular events in patients with advanced peripheral artery disease.
    Mittermayer F; Krzyzanowska K; Exner M; Mlekusch W; Amighi J; Sabeti S; Minar E; Müller M; Wolzt M; Schillinger M
    Arterioscler Thromb Vasc Biol; 2006 Nov; 26(11):2536-40. PubMed ID: 16931791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of stent implementation on plasma levels of asymmetric dimethylarginine in patients with or without ST-segment elevation acute myocardial infarction.
    Ajtay Z; Németh A; Sulyok E; Cziráki A; Szabados S; Martens-Lobenhoffer J; Awiszus F; Szabó C; Bode-Böger SM
    Int J Mol Med; 2010 Apr; 25(4):617-24. PubMed ID: 20198311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Asymmetric dimethylarginine predicts the risk of contrast-induced acute kidney injury in patients undergoing cardiac catheterization.
    Lu TM; Hsu CP; Chang CF; Lin CC; Lee TS; Lin SJ; Chan WL
    Atherosclerosis; 2016 Nov; 254():161-166. PubMed ID: 27744140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma asymmetric dimethylarginine and hyperemic myocardial blood flow in young subjects with borderline hypertension or familial hypercholesterolemia.
    Päivä H; Laakso J; Laine H; Laaksonen R; Knuuti J; Raitakari OT
    J Am Coll Cardiol; 2002 Oct; 40(7):1241-7. PubMed ID: 12383571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma asymmetric dimethylarginine and L-arginine levels in patients with cardiac syndrome X.
    Okyay K; Cengel A; Sahinarslan A; Tavil Y; Turkoglu S; Biberoglu G; Hasanoglu A
    Coron Artery Dis; 2007 Nov; 18(7):539-44. PubMed ID: 17925607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Asymmetric dimethylarginine is associated with macrovascular disease and total homocysteine in patients with type 2 diabetes.
    Krzyzanowska K; Mittermayer F; Krugluger W; Schnack C; Hofer M; Wolzt M; Schernthaner G
    Atherosclerosis; 2006 Nov; 189(1):236-40. PubMed ID: 16414052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.